11/01-2019 15:30:00: (ADDV-A.ST, ADDV-B.ST, ADDVISE-001.ST) Regulatory information- ADDvise receives order worth 3,2 MSEK

ADDvise Group AB's (publ) subsidiary Labrum has received an order from Cambrex Karlskoga worth 3,2 MSEK regarding laboratory furniture to Cambrex Karlskoga's newly built laboratory. Delivery is planned to Q2/Q3 2019.

For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71

Important information: 

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on January 11th 2019 at 15:30 CET.

About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.  

Ekstern link: http://news.cision.com/addvise/r/regulatory-information--addvise-receives-order-worth-3-2-msek,c2715640
Ekstern link: https://mb.cision.com/Main/12334/2715640/974920.pdf

Nyheten er levert av Cision.